What is the Price of Zoryve?
The list price for Zoryve (roflumilast) topical foam is $760.79 for a 60-gram (0.3%) unit. This price applies to both the brand-name drug and its generic version [1].
How Does Zoryve Work?
Zoryve is a topical phosphodiesterase-4 (PDE4) inhibitor used to treat plaque psoriasis [1]. PDE4 is an enzyme found in cells that plays a role in inflammation. By inhibiting PDE4, Zoryve helps to reduce inflammation associated with plaque psoriasis [1].
When Does Zoryve's Patent Protection End?
Zoryve is marketed by Arcutis Biotherapeutics. Information regarding specific patent expiry dates for Zoryve is available through patent tracking resources such as DrugPatentWatch.com [2]. Patent protection is crucial for pharmaceutical companies, as it allows them to recoup research and development costs before generic versions can enter the market.
What About Insurance Coverage for Zoryve?
While the list price is $760.79, many patients may not pay this amount out-of-pocket due to insurance. Arcutis Biotherapeutics offers a Zoryve co-pay card program that can significantly reduce the cost for commercially insured patients. This program can lower the out-of-pocket cost to as little as $10 for eligible individuals [3].
Are There Other Treatment Options for Plaque Psoriasis?
Yes, several other treatment options exist for plaque psoriasis, ranging from topical corticosteroids and vitamin D analogs to systemic therapies like biologics and oral medications. The choice of treatment depends on the severity and extent of the psoriasis, as well as individual patient factors.
What are the Potential Side Effects of Zoryve?
Common side effects reported in clinical trials for Zoryve topical foam include application site reactions such as itching, burning, stinging, redness, and pain [1]. Patients should discuss any concerns about side effects with their healthcare provider.
---
Sources:
[1] https://www.zoryve.com/
[2] https://drugpatentwatch.com/
[3] https://www.arcutis.com/